Asia Pacific active pharmaceutical ingredients (API) market will grow by 8.1% annually with a total addressable market cap of $ 1,098.6 billion over 2023-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.
Highlighted with 88 tables and 75 figures, this 196-page report “Asia Pacific Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific active pharmaceutical ingredients (API) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific active pharmaceutical ingredients (API) market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.
Based on Molecule, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Small Molecule APIs
• Large Molecule APIs
Based on Synthesis, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Biotech API
o by type
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Other Biotech APIs
o by Category
Innovative Biologic API
Generic Biosimilar API
o by Expression
Mammalian Expression
Microbial Expression
Yeast Expression
Insect Expression
Other Expression Technologies
• HPAPI
o Branded HPAPI
o Generic HPAPI
Based on Manufacturing Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Captive Manufacturing
o Branded Captive API
o Generic Captive API
• Merchant Manufacturing
o by Drug Type
Branded Merchant API
Generic Merchant API
o by Drug Synthesis
Merchant Synthetic API
Merchant Biotech API
By Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
By Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 32
2.2 Major Growth Drivers 36
2.3 Market Restraints and Challenges 44
2.4 Emerging Opportunities and Market Trends 47
2.5 Porter’s Fiver Forces Analysis 51
3 Segmentation of Asia Pacific Market by Molecule 55
3.1 Market Overview by Molecule 55
3.2 Small Molecule APIs 57
3.3 Large Molecule APIs 58
4 Segmentation of Asia Pacific Market by Synthesis 59
4.1 Market Overview by Synthesis 59
4.2 Synthetic API 61
4.2.1 Branded Synthetic API 62
4.2.2 Generic Synthetic API 63
4.3 Biotech API 64
4.3.1 Biotech API by Drug Type 65
4.3.1.1 Monoclonal Antibodies 66
4.3.1.2 Recombinant Proteins 67
4.3.1.3 Vaccines 68
4.3.1.4 Other Biotech APIs 69
4.3.2 Biotech API by Category 70
4.3.2.1 Innovative Biologic API 71
4.3.2.2 Generic Biosimilar API 72
4.3.3 Biotech API by Expression Technology 73
4.3.3.1 Mammalian Expression 74
4.3.3.2 Microbial Expression 75
4.3.3.3 Yeast Expression 76
4.3.3.4 Insect Expression 77
4.3.3.5 Other Expression Technologies 78
4.4 HPAPI 79
4.4.1 Branded HPAPI 80
4.4.2 Generic HPAPI 81
5 Segmentation of Asia Pacific Market by Manufacturing Process 82
5.1 Market Overview by Manufacturing Process 82
5.2 Captive Manufacturing 84
5.2.1 Branded Captive API 85
5.2.2 Generic Captive API 86
5.3 Merchant Manufacturing 87
5.3.1 Merchant Manufacturing by Drug Type 88
5.3.1.1 Branded Merchant API 89
5.3.1.2 Generic Merchant API 90
5.3.2 Merchant Manufacturing by Drug Synthesis 91
5.3.2.1 Merchant Synthetic API 92
5.3.2.2 Merchant Biotech API 93
6 Segmentation of Asia Pacific Market by Therapeutic Application 94
6.1 Market Overview by Therapeutic Application 94
6.2 Infectious Diseases 96
6.3 Oncology 97
6.4 Ophthalmology 98
6.5 Cardiovascular Disorders 99
6.6 Central Nervous System 100
6.7 Pulmonary Disorders 101
6.8 Orthopedics 102
6.9 Other Applications 103
7 Segmentation of Asia Pacific Market by Drug Type 104
7.1 Market Overview by Drug Type 104
7.2 Branded Prescription Drugs 106
7.3 Generic Prescription Drugs 107
7.4 OTC Drugs 108
8 Asia-Pacific Market 2022-2032 by Country 109
8.1 Overview of Asia-Pacific Market 109
8.2 China 112
8.3 Japan 114
8.4 India 117
8.5 Australia 119
8.6 South Korea 121
8.7 Rest of APAC Region 123
9 Competitive Landscape 125
9.1 Overview of Key Vendors 125
9.2 New Product Launch, Partnership, Investment, and M&A 128
9.3 Company Profiles 129
AbbVie Inc. 129
Astrazeneca 131
Aurobindo Pharma Ltd. 136
BASF 139
Bayer AG 142
Boehringer Ingelheim 146
Catalent Inc. 151
Dr. Reddy's Laboratories 154
F. Hoffmann-La Roche 156
GlaxoSmithKline plc 159
Lonza Group 164
Lupin Limited 168
Merck & Co., Inc. 171
Mylan NV 174
Novartis International AG 177
Pfizer Inc. 180
Sanofi 185
Sun Pharmaceutical Industries Ltd. 188
Teva Pharmaceutical Industries Ltd. 191
Thermo Fisher Scientific 193
Related Reports and Products 196
List of Tables:
Table 1. Snapshot of Asia Pacific Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 33
Table 5. World Health Spending by Region, $ bn, 2013-2020 42
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 43
Table 7. Main Product Trends and Market Opportunities in Asia Pacific Active Pharmaceutical Ingredients (API) Market 47
Table 8. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn 55
Table 9. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 59
Table 10. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn 61
Table 11. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn 65
Table 12. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn 70
Table 13. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn 73
Table 14. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn 79
Table 15. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 82
Table 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn 84
Table 17. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn 88
Table 18. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn 91
Table 19. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 94
Table 20. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn 104
Table 21. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 110
Table 22. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 113
Table 23. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 113
Table 24. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 113
Table 25. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 116
Table 26. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 116
Table 27. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 116
Table 28. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 118
Table 29. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 118
Table 30. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 118
Table 31. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 120
Table 32. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 120
Table 33. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 120
Table 34. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 122
Table 35. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 122
Table 36. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 122
Table 37. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2022-2032, $ bn 124
Table 38. AbbVie Inc.: Company Snapshot 129
Table 39. AbbVie Inc.: Business Segmentation 130
Table 40. AbbVie Inc.: Product Portfolio 130
Table 41. Astrazeneca: Company Snapshot 131
Table 42. Aurobindo Pharma Ltd.: Company Snapshot 136
Table 43. Aurobindo Pharma Ltd.: Product Portfolio 137
Table 44. BASF: Company Snapshot 139
Table 45. BASF: Business Segmentation 140
Table 46. Bayer AG: Company Snapshot 142
Table 47. Bayer AG: Business Segmentation 143
Table 48. Bayer AG: Product Portfolio 143
Table 49. Boehringer Ingelheim: Company Snapshot 146
Table 50. Boehringer Ingelheim: Product Portfolio 147
Table 51. Catalent Inc.: Company Snapshot 151
Table 52. Catalent Inc.: Business Segmentation 152
Table 53. Catalent Inc.: Product Portfolio 152
Table 54. Dr. Reddy's Laboratories: Company Snapshot 154
Table 55. Dr. Reddy's Laboratories: Business Segmentation 154
Table 56. F. Hoffmann-La Roche: Company Snapshot 156
Table 57. F. Hoffmann-La Roche: Clinical Trial Service 156
Table 58. F. Hoffmann-La Roche: Business Segmentation 157
Table 59. F. Hoffmann-La Roche: Revenue by Region 157
Table 60. GlaxoSmithKline: Company Snapshot 159
Table 61. GlaxoSmithKline: Business Segmentation 160
Table 62. GlaxoSmithKline: Product Portfolio 161
Table 63. Lonza Group: Company Snapshot 164
Table 64. Lonza Group: Business Segmentation 165
Table 65. Lonza Group: Product Portfolio 165
Table 66. Lupin Limited: Company Snapshot 168
Table 67. Lupin Limited: Business Segmentation 169
Table 68. Merck & Co., Inc.: Company Snapshot 171
Table 69. Merck & Co., Inc.: Business Segmentation 172
Table 70. Mylan NV: Company Snapshot 174
Table 71. Mylan NV: Breakdown of Revenue by Region, 2022 175
Table 72. Mylan NV: Breakdown of Revenue by Product Category, 2022 175
Table 73. Novartis International AG: Company Snapshot 177
Table 74. Novartis International AG: Business Segmentation 178
Table 75. Pfizer Inc.: Company Snapshot 180
Table 76. Pfizer Inc.: Business Segmentation 181
Table 77. Pfizer Inc.: Breakdown of Revenue by Product Category 181
Table 78. Pfizer Inc.: Breakdown of Revenue by Region 182
Table 79. Pfizer Inc.: Product Portfolio 182
Table 80. Sanofi: Company Snapshot 185
Table 81. Sanofi: Business Segmentation 186
Table 82. Sanofi: Breakdown of Revenue by Region 186
Table 83. Sun Pharmaceutical Industries Limited: Company Snapshot 188
Table 84. Teva Pharmaceutical Industries Ltd.: Company Snapshot 191
Table 85. Teva Pharmaceutical Industries Ltd.: Business Segmentation 192
Table 86. Thermo Fisher Scientific: Company Snapshot 193
Table 87. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, % 194
Table 88. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, % 194
